Evidence map›Paper›PMID 35069830›Full record

ArticleExperimental and therapeutic medicine2022

Mucosal gene expression profile of stricturing Crohn's disease: A preliminary study.

Cristian George Tieranu, Andrei Ovidiu Olteanu, Carmen Monica Preda, Nicolae Bacalbasa, Elena Milanesi, Maria Dobre, Ioana Tieranu, Teodora Ecaterina Manuc, Artsiom Klimko, Gabriel Becheanu and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Cristian George TieranuDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Andrei Ovidiu OlteanuDepartment of Gastroenterology, 'Elias' Emergency University Hospital, 011461 Bucharest, Romania.
Carmen Monica PredaDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Nicolae BacalbasaDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Elena MilanesiDepartment of Radiobiology, 'Victor Babeş' National Institute of Pathology, 050096 Bucharest, Romania.
Maria DobreDepartment of Pathology, 'Victor Babeş' National Institute of Pathology, 050096 Bucharest, Romania.
Ioana TieranuDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Teodora Ecaterina ManucDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Artsiom KlimkoDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Gabriel BecheanuDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Elena Mirela IonescuDepartment of Gastroenterology, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Carol Davila University of Medicine and Pharmacy · ROInstitutul National Victor Babes · ROClinical Emergency Hospital Bucharest · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal strictures are an important complication of Crohn's disease (CD), with ~40% of patients developing symptomatic obstruction within 10 years of diagnosis. However, there is a paucity of research examining the mechanisms driving the development of fibrotic strictures in CD. The present study aimed to identify the mucosal markers associated with stricturing complications by examining the differences in the gene expression profiles of two patient cohorts: Patients diagnosed with inflammatory CD (n=12) and patients with stricturing CD (n=9). For each patient, a paired sample of inflamed and uninflamed mucosa was isolated and assessed by quantitative PCR using a large panel of genes associated with inflammatory bowel disease. The presents study revealed a significantly increased level of four genes in the mucosa of patients with strictures compared with the inflammatory pattern of the disease: Formyl-peptide receptor 1 [P=0.019; fold change (FC)=11.6], C-C chemokine receptor type 1 (P=0.035; FC=5.44), IFN-γ-inducible protein 10 (P=0.037; FC=3.8) and C-C chemokine ligand 25 (P=0.048; FC=3.56). The augmented expression of these four genes in the CD stricturing phenotype, if confirmed in larger cohorts of patients, could help elucidate the mechanisms leading to disease-associated complications.

Indexed as

C-C chemokine ligand 25C-C chemokine receptor type 1Crohn's diseaseformyl-peptide receptor 1genesIFN-γ-inducible protein 10strictures

Identifiers

PMID35069830
PMCPMC8756406
OpenAlexW4200327606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.